Boothbay Fund Management, LLC Biocryst Pharmaceuticals Inc Put Options Transaction History

Boothbay Fund Management, LLC

  • $3.37 Billion
  • Q2 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 15, 2024
BUY
$4.89 - $7.65 $360,393 - $563,805
73,700 New
73,700 $374,000
Q2 2022

Aug 15, 2022
SELL
$7.89 - $17.88 $530,997 - $1.2 Million
-67,300 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$11.56 - $19.76 $777,988 - $1.33 Million
67,300 New
67,300 $1.09 Million

Others Institutions Holding BCRX

# of Institutions
257
Shares Held
173M
Call Options Held
397K
Put Options Held
444K
View Full List

About BIOCRYST PHARMACEUTICALS INC

BCRX Quotes by TradingView
  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.42B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email